Keenova Therapeutics plc: Pain trials
The registry lists 16 Pain studies with Keenova Therapeutics plc as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 1 3Phase 3 11Phase 4 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Drug Interactions Between Morphine and Orally or IV Administered AcetaminophenCompletedNCT02848729Phase 4Results posted
- Reduction in Pain Intensity Following IV or Oral Pain-relieving ProductsCompletedNCT02678416Phase 4Results posted
- Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.CompletedNCT00801398Phase 3Results posted
- Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric SubjectsTerminatedNCT00765856Phase 3Results posted
- A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) PainCompletedNCT00631319Phase 3Results posted
- Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric InpatientsCompletedNCT00598702Phase 3Results posted
- Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop PainCompletedNCT00564486Phase 3Results posted
- Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back PainCompletedNCT00549042Phase 3Results posted
- Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric InpatientsCompletedNCT00493246Phase 1Results posted
- Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic SurgeryCompletedNCT00399568Phase 3Results posted
- Pharmacokinetics, Bioavailability and Safety of PENNSAID® GelCompletedNCT01202799Phase 1
- Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.CompletedNCT01173627Phase 1
- Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic PainCompletedNCT00911287Phase 3
- Open Label Assessment of Long-Term Safety and UtilityCompletedNCT00904449Phase 3
- Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic EfficacyCompletedNCT00904280Phase 3
- Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel SyndromeTerminatedNCT00266214Phase 3